Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.

× No keyword cloud information.

10 in total

1. A survey of applications of biological products for drug interference of immunogenicity assays.

Authors: Yow-Ming C Wang; Lanyan Fang; Lin Zhou; Jie Wang; Hae-Young Ahn
Journal: Pharm Res Date: 2012-08-18 Impact factor: 4.200

2. Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity.

Authors: Andreas Seidl; Otmar Hainzl; Marleen Richter; Robert Fischer; Stephan Böhm; Britta Deutel; Martin Hartinger; Jörg Windisch; Nicole Casadevall; Gerard Michel London; Iain Macdougall
Journal: Pharm Res Date: 2011-11-18 Impact factor: 4.200

Review 3. Anemia, diabetes, and chronic kidney disease.

Authors: Uzma Mehdi; Robert D Toto
Journal: Diabetes Care Date: 2009-07 Impact factor: 17.152

Review 4. Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

Authors: Walter H Hörl
Journal: Drugs Date: 2013-02 Impact factor: 9.546

5. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).

Authors: Iain C Macdougall; Nicole Casadevall; Francesco Locatelli; Christian Combe; Gerard M London; Salvatore Di Paolo; Andreas Kribben; Danilo Fliser; Hans Messner; John McNeil; Paul Stevens; Antonio Santoro; Angel L M De Francisco; Paul Percheson; Anna Potamianou; Arnaud Foucher; Daniel Fife; Véronique Mérit; Els Vercammen
Journal: Nephrol Dial Transplant Date: 2014-09-19 Impact factor: 5.992

6. Antibody-mediated pure red cell aplasia (PRCA) on switching from darbepoetin alfa to epoetin beta: what are the implications?

Authors: José Assunção; José Vinhas
Journal: NDT Plus Date: 2008-06-10

7. Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients.

Authors: Maryam Rahbar; Zahra Chitsazian; Firoozeh Abdoli; Seyed-Masoud Moeini Taba; Hosein Akbari
Journal: J Nephropathol Date: 2016-08-22

8. Modified recombinant human erythropoietin with potentially reduced immunogenicity.

Authors: Thanutsorn Susantad; Mayuree Fuangthong; Kannan Tharakaraman; Phanthakarn Tit-Oon; Mathuros Ruchirawat; Ram Sasisekharan
Journal: Sci Rep Date: 2021-01-15 Impact factor: 4.379

9. Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone.

Authors: Nozomi Okahashi; Masayuki Kubo; Ei Hoshino; Masahito Uchihara; Itsuto Amano; Haruyuki Tanaka
Journal: Intern Med Date: 2021-12-28 Impact factor: 1.282

10. A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients.

Authors: Chie Ogawa; Ken Tsuchiya; Naohisa Tomosugi; Kunimi Maeda
Journal: Int J Mol Sci Date: 2020-09-28 Impact factor: 5.923

10 in total